Gottlieb

Ventra Health Announces Jason Greenberg, M.D. as Chief Client Officer.

Retrieved on: 
Tuesday, March 1, 2022
University of California, Irvine Medical Center, Practice management, Leadership, Hospital, Industry, Harvard University, Physician, Harvard Society of Fellows, Organization, ASA, University, Anesthesia, Solution, Mass General Brigham, Brigham and Women's Hospital, Raffles Medical Group, Practice management software, Medicine, CEO, Hospital medicine, University of Chicago, Emergency medicine, Selma Calmes, Face, Economics, Ventra, Northwestern University, Gottlieb

Dr. Greenberg joins Ventra Health from Anesthesia Care Associates Medical Group, where he led as President and CEO.

Key Points: 
  • Dr. Greenberg joins Ventra Health from Anesthesia Care Associates Medical Group, where he led as President and CEO.
  • Ventra Health's CEO,Michael O'Boyle, stated: "The addition of Dr. Greenberg is a seminal moment in the development of Ventra Health's executive leadership team.
  • Ventra Health is a leading healthcare organization focused on tech-enabled revenue cycle management, practice management, and advisory solutions for hospital-based physicians.
  • Backed by Varsity Healthcare Partners, Ventra Health represents the acquisitions of DuvaSawko, Gottlieb, and Abeo, who collectively served the emergency medicine, hospital medicine, and anesthesia market.

Real Chemistry’s Global President, Jennifer Gottlieb, Appointed to the Ad Council’s Board of Directors

Retrieved on: 
Thursday, October 28, 2021
Public Relations, Investor Relations, Marketing, Advertising, Communications, Other Communications, Hurricane Katrina, Ad Council, Technology, LinkedIn, Publicis Healthcare Communications Group, Creativity, Industry, Knowledge, Real, Gottlieb, Twitter, History, Advertising, Health, Patient, YouTube, Social change, Marketing, Board, CEO, Facebook, COVID-19, Multimedia, Council, Awareness, Friends, Lists of disasters, COVID, Chemistry, World War II, Board of directors, Pharmaceutical industry, Management, Sales, Real Chemistry, the Ad Council, REAL CHEMISTRY, THE AD COUNCIL

Real Chemistry, a leading global health innovation company committed to making the world a healthier place for all, is proud to announce that Jennifer Gottlieb has been appointed to the Ad Councils Board of Directors.

Key Points: 
  • Real Chemistry, a leading global health innovation company committed to making the world a healthier place for all, is proud to announce that Jennifer Gottlieb has been appointed to the Ad Councils Board of Directors.
  • We are delighted to have Jennifer join our Board of Directors and bring her wealth of experience and knowledge of the healthcare industry to our organization, said Lisa Sherman, President and CEO of the Ad Council.
  • Gottlieb was elected to the Ad Council Board along with 17 new members following the Boards October 27 meeting.
  • To learn more, visit AdCouncil.org , follow the Ad Council's communities on Facebook and Twitter , and view the creative on YouTube .

SALT Draws Record Vaccinated Audience to Hear Pandemic-Influenced Views from Top Global Financial & Tech Minds

Retrieved on: 
Thursday, September 16, 2021
Titan, Public policy, RET, Investment, Science, SkyBridge Capital, SALT, Democrat, FDA, Gottlieb, Technology, Vaccination, Entrepreneurship, Interview, Conference, Economics, HEPA, Tax, Climate change, The Carlyle Group, Pains, White House, Risk, Employment, LinkedIn, HV, Squawk Box, Safety, Industry, Policy, Battle of the Network Reality Stars, Environment, Commissioner, COVID-19, Instagram, Twitter, CNBC, COVID, Racism, Politics, 2016 Florida Republican presidential primary, Leadership, Public relations, Pharmaceutical industry, Nightclub

Certainly, we've made a lot of progress on employment, a lot of progress on economic growth, but we have more work to do.

Key Points: 
  • Certainly, we've made a lot of progress on employment, a lot of progress on economic growth, but we have more work to do.
  • The next SALT event is tentatively slated to take place in Abu Dhabi in the first half of 2022.
  • SALT is a global thought leadership forum devoted to unlocking growth opportunities in finance, economics, entrepreneurship, public policy, technology, and philanthropy.
  • Visit www.salt.org to learn more or connect with @SALTConference on Twitter , Facebook , LinkedIn or Instagram or by using #SALTNY.

Davis Polk Welcomes Leading International Trade and National Security Lawyer Paul Marquardt in Washington DC

Retrieved on: 
Monday, June 14, 2021
Legal, Professional services, Cleary Gottlieb Steen & Hamilton, Committee on Foreign Investment in the United States, Cleary, Gottlieb, Davis Polk., Davis Polk’s AML, Sanctions & CFIUS Practice., DAVIS POLK., DAVIS POLK’S AML, SANCTIONS & CFIUS PRACTICE.

Davis Polk today announced that Paul Marquardt, a leading economic sanctions and national security lawyer, has joined the firm as a partner in the Financial Institutions Group in Washington DC.

Key Points: 
  • Davis Polk today announced that Paul Marquardt, a leading economic sanctions and national security lawyer, has joined the firm as a partner in the Financial Institutions Group in Washington DC.
  • Paul is an exceptionally talented practitioner and a fantastic addition to our distinguished regulatory team in Washington.
  • Mr. Marquardt joins Davis Polk from Cleary Gottlieb Steen & Hamilton LLP, where he led the foreign investment and national security practice.
  • Chambers USA recognizes Mr. Marquardt as a leading international trade practitioner, in both Export Controls & Economic Sanctions and CFIUS.

DuvaSawko and abeo Complete Strategic Combination with Gottlieb

Retrieved on: 
Monday, May 3, 2021
Other Professional Services, Health, Legal, Insurance, Human resources, Finance, Consulting, Small business, Banking, Accounting, Professional services, Practice Management, General Health, Hospitals, DuvaSawko / abeo, Gottlieb, DUVASAWKO / ABEO, GOTTLIEB

Terms of the transaction were not disclosed.\nCombining DuvaSawko / abeo and Gottlieb will create one of the largest multi-vertical RCM platforms with approximately 9.0 million emergency medicine visits and 3.5 million anesthesia cases processed annually across 40+ states.

Key Points: 
  • Terms of the transaction were not disclosed.\nCombining DuvaSawko / abeo and Gottlieb will create one of the largest multi-vertical RCM platforms with approximately 9.0 million emergency medicine visits and 3.5 million anesthesia cases processed annually across 40+ states.
  • \xe2\x80\x9cThe addition of Craig Radulovich and the leadership at Gottlieb further enhances the DuvaSawko / abeo team with some of the best RCM specialists in the industry.
  • We are excited to leverage Gottlieb\xe2\x80\x99s robust technology and service platforms strengthening our deep commitment to improving our clients\xe2\x80\x99 financial performance.\xe2\x80\x9d\nRadulovich added, \xe2\x80\x9cThe strategic combination with DuvaSawko / abeo will enable Gottlieb to extend its market leadership and leverage industry-best standards across both companies.
  • This transaction marks the first since the transformative merger between DuvaSawko and abeo that was completed in November 2020.\nKirkland & Ellis LLP acted as legal adviser to VHP and DuvaSawko / abeo.

SimplePractice announces SimpleSummit virtual retreat

Retrieved on: 
Thursday, April 22, 2021
Lori Gottlieb, Gottlieb

b'LOS ANGELES, April 22, 2021 /PRNewswire/ -- SimplePractice , an EngageSmart healthcare solution and leading EHR platform for private practice, today announced the upcoming virtual retreat SimpleSummit , taking place May 21 to May 23 from 9:30 a.m. PT - 1 p.m. PT.\nThe summit will provide relevant content designed specifically for the needs of SimplePractice customers and members of the private practice community.

Key Points: 
  • b'LOS ANGELES, April 22, 2021 /PRNewswire/ -- SimplePractice , an EngageSmart healthcare solution and leading EHR platform for private practice, today announced the upcoming virtual retreat SimpleSummit , taking place May 21 to May 23 from 9:30 a.m. PT - 1 p.m. PT.\nThe summit will provide relevant content designed specifically for the needs of SimplePractice customers and members of the private practice community.
  • It will also incorporate meditation, making this a unique virtual retreat that encourages attendees to hit refresh and look ahead after a trying year.
  • We\'re looking forward to engaging on important topics around mental health and wellness," said SimplePractice CEO and co-founder Howard Spector.
  • "\nKey speakers at SimpleSummit include New York Times bestselling author and psychotherapist Lori Gottlieb, Dr. Ebony Butler, Dr. Cassidy Freitas, and SimplePractice Co-Founder Ralph Zimmerman.

MacroGenics to Participate in Upcoming Investor Conferences

Retrieved on: 
Monday, January 11, 2021
American Enterprise Institute, Pfizer, Scott Gottlieb, Trademark, Gottlieb, Marketing, Business, Market economics)

A corporate overview provided by MacroGenics management will be available for on-demand viewing from January 11 - 14, 2021.

Key Points: 
  • A corporate overview provided by MacroGenics management will be available for on-demand viewing from January 11 - 14, 2021.
  • In addition, MacroGenics President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will participate in a panel discussion on Precision Medicine hosted by Scott Gottlieb, M.D., Former Commissioner of the U.S. Food and Drug Administration.
  • MacroGenics management will participate in one-on-one meetings and provide a corporate overview onJanuary 14, 2021 at 10:00 AM ET.
  • MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

Former FDA Commissioner Scott Gottlieb Joins Aetion's Board of Directors

Retrieved on: 
Tuesday, September 17, 2019
Health, American Enterprise Institute, Scott Gottlieb, United States Department of Health and Human Services, Articles, Commissioner of Food and Drugs, Food and Drug Administration, Gottlieb, United States administrative law

NEW YORK, Sept. 17, 2019 /PRNewswire/ --Today, Aetion , the health care technology company that delivers real-world evidence (RWE) for life sciences companies, payers, and regulatory agencies, announced that former Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb has joined its board of directors.

Key Points: 
  • NEW YORK, Sept. 17, 2019 /PRNewswire/ --Today, Aetion , the health care technology company that delivers real-world evidence (RWE) for life sciences companies, payers, and regulatory agencies, announced that former Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb has joined its board of directors.
  • Gottlieb served as the 23rd Commissioner of Food and Drugs from May 2017 to April 2019.
  • Gottlieb first served at the FDA under President George W. Bush as Deputy Commissioner for Medical and Scientific Affairs as well as a senior advisor to the FDA Commissioner.
  • Gottlieb joins the Aetion Board of Directors during a momentous year for the company.

Gottlieb, a Revenue Cycle Management Leaders, Launches New Website

Retrieved on: 
Tuesday, August 13, 2019
Healthcare in the United States, Gottlieb, Revenue Cycle Management, Hospital medicine, Vocus

JACKSONVILLE, Fla., Aug. 13, 2019 /PRNewswire-PRWeb/ -- Gottlieb, an industry leader in emergency department and hospitalist medicine revenue cycle management, announced this week the launch of their new website .

Key Points: 
  • JACKSONVILLE, Fla., Aug. 13, 2019 /PRNewswire-PRWeb/ -- Gottlieb, an industry leader in emergency department and hospitalist medicine revenue cycle management, announced this week the launch of their new website .
  • Responsive across all devices, the new website includes the addition of video resources, Insight , the business intelligence platform, Gottlieb solutions, and industry events.
  • "This website redesign is just another way Gottlieb shows its commitment to creating the best experience for our clients and website visitors."
  • As a national leader in revenue cycle management, physician education, coding, and documentation training; Gottlieb consistently improves our clients' practices.

Scott Gottlieb Elected to Pfizer’s Board of Directors

Retrieved on: 
Thursday, June 27, 2019
Biotechnology, General Health, Health, Pharmaceutical, Pfizer, Businesspeople, Industries, Business, Scott Gottlieb, Ian Read, PFE, Gottlieb

Pfizer Inc. (NYSE:PFE) today announced the election of Dr. Scott Gottlieb to its Board of Directors, effective immediately.

Key Points: 
  • Pfizer Inc. (NYSE:PFE) today announced the election of Dr. Scott Gottlieb to its Board of Directors, effective immediately.
  • Dr. Gottlieb, age 47, was also appointed to the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizers Board.
  • We are fortunate to have Dr. Gottlieb join Pfizers Board of Directors, stated Ian Read, Pfizer Executive Chairman.
  • We welcome Dr. Gottlieb to Pfizers Board of Directors, said Dr. Albert Bourla, Pfizer Chief Executive Officer.